Astrana Health (ASTH) Financials

$39.76 +0.75 (+1.92%)

Closing price 05/13/2026 04:00 PM Eastern

Extended Trading

$40.00 +0.24 (+0.60%)

As of 05/13/2026 07:59 PM Eastern

Annual Income Statements for Astrana Health

This table shows Astrana Health's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	3/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-1.80	11	26	11	14	38	69	45	61	43	22
Consolidated Net Income / (Loss)	-1.35	10	46	60	18	122	46	46	58	50	24
Net Income / (Loss) Continuing Operations	-1.35	10	46	60	18	122	46	46	58	50	24
Total Pre-Tax Income	-1.18	19	50	83	26	178	78	87	90	81	40
Total Operating Income	-0.69	12	35	88	32	81	98	104	85	89	79
Total Gross Profit	11	51	83	155	94	148	178	199	215	271	342
Total Revenue	33	306	356	520	561	687	774	1,144	1,387	2,035	3,182
Operating Revenue	33	282	356	520	561	687	774	1,144	1,387	2,035	3,182
Total Cost of Revenue	22	255	273	365	466	539	596	945	1,172	1,763	2,840
Operating Cost of Revenue	22	255	273	361	468	539	596	945	1,172	1,763	2,840
Total Operating Expenses	12	39	48	66	62	67	80	95	130	182	263
Selling, General & Admin Expense	11	21	26	43	41	49	62	78	113	154	217
Depreciation Expense	0.33	18	19	19	18	18	18	18	18	28	46
Total Other Income / (Expense), net	-0.49	7.15	15	-5.81	-6.58	98	-20	-18	5.23	-8.53	-39
Interest Expense	1.33	0.06	0.08	0.56	4.73	9.50	5.39	7.92	16	33	50
Interest & Investment Income	-	5.25	14	-6.87	-4.88	106	-0.54	7.60	20	19	14
Other Income / (Expense), net	0.84	1.96	1.05	1.62	3.03	1.08	-14	-17	1.54	5.61	-2.86
Income Tax Expense	0.16	8.82	3.89	22	8.17	56	32	41	32	31	16
Net Income / (Loss) Attributable to Noncontrolling Interest	0.45	-1.43	20	49	3.56	84	-23	0.57	-2.87	6.78	1.59
Basic Earnings per Share	($0.37)	$0.46	$1.01	$0.33	$0.41	$1.03	$1.57	$1.00	$1.30	$0.91	$0.46
Weighted Average Basic Shares Outstanding	4.89M	24.67M	25.53M	32.89M	52.80M	54.59M	55.96M	57.44M	55.42M	56.25M	55.60M
Diluted Earnings per Share	($0.37)	$0.41	$0.90	$0.29	$0.39	$1.01	$1.52	$0.99	$1.29	$0.90	$0.46
Weighted Average Diluted Shares Outstanding	4.89M	27.97M	28.66M	37.91M	52.80M	54.59M	55.96M	57.44M	55.42M	56.25M	55.60M
Weighted Average Basic & Diluted Shares Outstanding	4.89M	5.21M	6.95M	32.80M	52.80M	54.59M	55.96M	57.44M	55.42M	56.25M	55.60M

This table shows Astrana Health's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025
Period end date	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2026	6/30/2025	9/30/2025	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	13	22	12	15	19	16	-6.95	14	9.42	0.37	6.00
Consolidated Net Income / (Loss)	17	28	-0.09	17	22	19	-7.78	13	10	1.08	6.56
Net Income / (Loss) Continuing Operations	17	28	-0.09	17	22	19	-7.78	13	10	1.08	6.56
Total Pre-Tax Income	31	38	0.92	24	32	27	-1.90	20	17	5.67	7.51
Total Operating Income	27	39	-3.87	30	30	28	0.72	29	20	19	18
Total Gross Profit	55	73	39	74	73	73	50	106	78	97	95
Total Revenue	348	348	353	404	486	479	665	965	655	956	951
Operating Revenue	348	348	353	404	486	479	665	965	655	956	951
Total Cost of Revenue	293	275	314	330	413	405	615	859	577	859	855
Operating Cost of Revenue	293	275	314	330	413	405	615	859	577	859	855
Total Operating Expenses	28	34	43	44	43	45	50	77	58	78	77
Selling, General & Admin Expense	24	29	38	39	36	38	42	62	51	62	60
Depreciation Expense	4.25	4.31	4.90	5.10	7.44	7.26	8.13	15	6.90	16	16
Total Other Income / (Expense), net	4.46	-1.07	4.80	-6.14	1.83	-1.61	-2.62	-8.82	-3.52	-14	-11
Interest Expense	3.63	3.78	5.42	7.59	8.59	8.86	8.07	16	7.38	18	18
Interest & Investment Income	6.05	1.18	7.07	4.63	4.42	5.13	4.79	5.54	2.72	4.54	5.16
Other Income / (Expense), net	2.04	1.53	3.15	-3.18	6.00	2.11	0.67	1.75	1.15	-0.36	1.47
Income Tax Expense	14	10	1.02	7.14	10	7.83	5.88	6.58	6.61	4.59	0.94
Net Income / (Loss) Attributable to Noncontrolling Interest	4.31	5.91	-12	2.03	2.70	2.89	-0.83	-1.31	0.79	0.70	0.56
Basic Earnings per Share	$0.28	$0.47	$0.27	$0.31	$0.40	$0.34	($0.14)	$0.30	$0.19	$0.01	$0.12
Weighted Average Basic Shares Outstanding	57.56M	58.28M	55.42M	56.03M	56.21M	56.25M	56.25M	55.72M	56.06M	56.29M	55.60M
Diluted Earnings per Share	$0.28	$0.47	$0.26	$0.31	$0.40	$0.33	($0.14)	$0.29	$0.19	$0.01	$0.12
Weighted Average Diluted Shares Outstanding	57.56M	58.28M	55.42M	56.03M	56.21M	56.25M	56.25M	55.72M	56.06M	56.29M	55.60M
Weighted Average Basic & Diluted Shares Outstanding	57.56M	58.28M	55.42M	56.03M	56.21M	56.25M	56.25M	55.72M	56.06M	56.29M	55.60M

This table details how cash moves in and out of Astrana Health's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	3/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	-1.82	-4.19	64	-11	-3.63	90	39	55	6.13	-5.05	145
Net Cash From Operating Activities	-0.27	22	52	25	14	46	70	82	68	52	115
Net Cash From Continuing Operating Activities	-0.27	22	52	25	14	46	70	82	68	52	115
Net Income / (Loss) Continuing Operations	-1.35	10	46	60	18	122	46	46	58	50	24
Consolidated Net Income / (Loss)	-1.35	10	46	60	18	122	46	46	58	50	24
Depreciation Expense	0.33	18	19	19	18	18	18	18	18	28	46
Amortization Expense	0.52	-	-	0.00	0.47	1.35	1.08	0.94	1.06	1.83	4.05
Non-Cash Adjustments To Reconcile Net Income	0.50	0.99	-6.49	-4.18	9.31	-100	31	38	27	37	43
Changes in Operating Assets and Liabilities, net	-0.28	-7.21	-6.57	-50	-32	4.08	-25	-20	-36	-64	-2.22
Net Cash From Investing Activities	-3.20	-8.96	27	-25	-181	95	17	-7.11	-66	-192	-539
Net Cash From Continuing Investing Activities	-3.20	-8.96	27	-25	-181	95	17	-7.11	-66	-192	-539
Purchase of Property, Plant & Equipment	-0.04	-3.31	-2.08	-1.17	-1.04	-1.16	-19	-23	-29	-8.03	-10
Acquisitions	-3.36	-2.44	0.00	-17	-53	-21	-16	-16	-6.84	-152	-549
Purchase of Investments	-	-5.21	-10	-7.91	-127	-1.94	-28	-1.85	-26	-30	-1.71
Divestitures	0.00	0.00	37	0.00	0.00	53	6.38	-	0.00	0.00	15
Other Investing Activities, net	-0.24	0.00	0.23	-	0.00	0.00	5.93	1.96	-3.68	-2.23	6.32
Net Cash From Financing Activities	1.66	-17	-15	-11	163	-52	-48	-20	3.42	135	569
Net Cash From Continuing Financing Activities	1.66	-17	-15	-11	163	-52	-48	-20	3.42	135	569
Repayment of Debt	-1.47	-2.26	-9.10	-0.59	-55	-9.61	-239	-4.43	-208	-18	-512
Repurchase of Common Equity	-	-0.52	-3.18	-5.05	-13	-0.54	-6.47	-9.25	-10	-0.94	-15
Payment of Dividends	-0.60	-26	-10	-18	-62	-52	-33	-19	-62	-4.04	-7.89
Issuance of Debt	3.00	0.00	5.00	8.00	290	0.00	181	3.60	285	172	1,119
Other Financing Activities, net	-0.00	0.26	0.59	4.00	3.12	11	9.06	8.63	-1.00	-14	-14
Cash Interest Paid	0.77	0.06	0.05	0.46	4.26	8.51	4.16	6.67	14	30	46
Cash Income Taxes Paid	0.03	29	24	24	20	62	37	47	57	44	0.00

This table details how cash moves in and out of Astrana Health's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025
Period end date	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025
Net Change in Cash & Equivalents	20	-20	20	41	-9.49	23	-60	-30	81	124	-30
Net Cash From Operating Activities	26	15	19	5.98	23	34	-11	17	91	9.96	-2.89
Net Cash From Continuing Operating Activities	26	15	19	5.98	23	34	-11	17	91	9.96	-2.89
Net Income / (Loss) Continuing Operations	17	28	-0.09	17	22	19	-7.78	6.22	10	1.08	6.56
Consolidated Net Income / (Loss)	17	28	-0.09	17	22	19	-7.78	6.22	10	1.08	6.56
Depreciation Expense	4.25	4.31	4.90	5.10	7.44	7.26	8.13	6.85	6.90	16	16
Amortization Expense	0.24	0.24	0.35	0.46	0.46	0.46	0.45	0.69	1.05	1.15	1.16
Non-Cash Adjustments To Reconcile Net Income	4.46	5.98	5.22	14	-30	7.62	11	1.82	68	-4.91	-30
Changes in Operating Assets and Liabilities, net	-0.63	-23	8.92	-30	23	-0.34	-23	1.05	5.00	-2.96	2.71
Net Cash From Investing Activities	-5.19	-35	-11	-71	-80	-8.11	-33	-2.39	-1.08	-534	-1.06
Net Cash From Continuing Investing Activities	-5.19	-35	-11	-71	-80	-8.11	-33	-2.39	-1.08	-534	-1.06
Purchase of Property, Plant & Equipment	-11	-4.11	-7.06	-0.37	-2.84	-2.30	-2.53	-3.07	-1.42	-2.55	-3.06
Acquisitions	0.35	-5.02	-1.84	-51	-70	-0.91	-31	0.00	-	-549	-0.05
Other Investing Activities, net	8.82	-0.70	-1.00	0.01	-2.31	0.10	-	0.68	1.47	2.19	2.06
Net Cash From Financing Activities	-0.96	-0.51	12	106	47	-3.19	-15	-44	-8.64	648	-26
Net Cash From Continuing Financing Activities	-0.96	-0.51	12	106	47	-3.19	-15	-44	-8.64	648	-26
Repayment of Debt	-0.31	-0.35	-208	-3.68	-7.56	-4.14	-3.89	-447	-7.90	-50	-8.75
Payment of Dividends	-0.72	-1.42	-60	0.03	-1.93	-0.22	-1.94	-5.46	-0.75	-0.10	-1.56
Other Financing Activities, net	-0.05	-	-0.73	0.00	-3.58	-0.39	-9.22	-4.05	-1.00	-8.79	-0.61
Cash Interest Paid	3.27	3.41	4.58	6.43	8.18	8.58	7.23	7.36	6.18	17	16
Cash Income Taxes Paid	-	-	49	0.19	36	2.53	5.67	4.34	0.39	-	-4.73

This table presents Astrana Health's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	3/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	15	350	491	513	729	817	867	966	933	1,355	2,219
Total Current Assets	9.85	81	144	173	329	339	404	428	462	638	863
Cash & Equivalents	5.01	55	100	107	103	193	233	288	294	288	429
Short-Term Investments	-	1.05	1.14	1.13	117	68	53	5.57	2.50	0.00	0.00
Note & Lease Receivable	-	-	-	0.00	23	0.00	4.00	3.12	-	0.00	4.93
Accounts Receivable	4.05	22	20	57	76	61	90	117	137	305	401
Prepaid Expenses	0.79	1.85	5.14	7.39	10	17	19	15	17	25	26
Current Deferred & Refundable Income Taxes	-	-	-	-	-	-	-	0.00	11	19	1.80
Plant, Property, & Equipment, net	0.58	10	14	13	12	30	53	109	7.17	14	57
Total Noncurrent Assets	4.56	258	333	327	388	449	410	430	465	702	1,298
Long-Term Investments	-	35	22	35	29	80	43	43	32	48	26
Noncurrent Note & Lease Receivables	-	5.20	15	18	0.00	4.63	0.57	0.00	26	51	49
Goodwill	2.17	103	190	186	239	239	246	269	279	419	865
Intangible Assets	1.38	108	104	87	103	87	83	77	72	118	271
Noncurrent Deferred & Refundable Income Taxes	-	-	-	-	-	-	16	16	16	16	26
Other Noncurrent Operating Assets	0.75	6.94	2.38	1.95	17	38	21	25	40	49	61
Total Liabilities & Shareholders' Equity	15	350	491	513	729	817	867	966	933	1,355	2,219
Total Liabilities	16	100	154	106	368	372	357	408	523	841	1,660
Total Current Liabilities	5.97	51	110	72	105	115	115	149	219	366	615
Short-Term Debt	1.04	0.10	0.61	0.04	9.50	11	0.78	0.62	20	9.38	48
Accounts Payable	3.34	9.13	20	27	29	46	54	58	68	114	199
Current Deferred & Payable Income Tax Liabilities	-	2.81	3.20	12	4.53	4.22	0.00	4.28	-	-	0.00
Other Current Liabilities	1.59	39	85	34	62	54	59	85	131	242	368
Total Noncurrent Liabilities	10	49	45	34	262	257	242	259	304	475	1,045
Long-Term Debt	7.69	-	-	0.00	232	230	183	203	259	425	991
Noncurrent Deferred & Payable Income Tax Liabilities	0.17	47	25	20	18	11	30	14	4.07	4.56	5.49
Other Noncurrent Operating Liabilities	2.14	2.00	19	1.19	12	16	29	41	41	45	49
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	0.00	163	172	225	169	114	57	14	-206	-203	-235
Total Equity & Noncontrolling Interests	-0.99	88	164	182	192	331	454	544	617	717	793
Total Preferred & Common Equity	-2.82	87	160	181	192	331	448	543	614	713	779
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	-2.82	87	160	181	192	331	448	543	614	713	779
Common Stock	17	88	158	163	160	261	311	360	371	426	471
Retained Earnings	-19	-0.77	1.73	18	32	70	137	182	243	286	308
Noncontrolling Interest	1.83	0.38	4.24	1.00	0.79	0.09	5.94	1.75	2.43	4.01	14

This table presents Astrana Health's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2026	6/30/2025	9/30/2025
Total Assets	943	999	1,027	1,073	1,226	1,252	1,285	2,359	1,442	2,237
Total Current Assets	444	455	465	476	539	570	597	1,004	729	884
Cash & Equivalents	184	275	294	274	335	325	348	478	340	462
Short-Term Investments	33	4.11	3.79	3.02	2.49	2.38	2.35	0.00	2.42	1.22
Note & Lease Receivable	0.00	0.97	0.97	0.97	-	-	-	4.66	-	5.91
Accounts Receivable	202	153	151	184	184	203	210	495	357	391
Prepaid Expenses	12	22	15	14	17	17	21	26	22	23
Current Deferred & Refundable Income Taxes	12	0.00	-	-	0.00	22	16	0.00	7.89	0.00
Plant, Property, & Equipment, net	104	113	124	129	7.99	10	12	60	18	56
Total Noncurrent Assets	396	431	438	468	679	672	676	1,295	695	1,297
Long-Term Investments	40	44	49	47	42	42	44	27	47	27
Noncurrent Note & Lease Receivables	2.64	-	-	25	47	49	55	49	48	48
Goodwill	257	269	274	276	410	410	410	875	417	863
Intangible Assets	73	78	74	74	120	116	109	257	106	285
Noncurrent Deferred & Refundable Income Taxes	-	16	16	16	16	16	16	26	16	16
Other Noncurrent Operating Assets	22	24	25	30	44	39	43	61	61	57
Total Liabilities & Shareholders' Equity	943	999	1,027	1,073	1,226	1,252	1,285	2,359	1,442	2,237
Total Liabilities	390	434	444	458	774	774	778	1,781	904	1,682
Total Current Liabilities	156	173	186	203	355	310	313	745	460	630
Short-Term Debt	3.16	0.62	2.63	2.99	21	17	15	48	13	48
Accounts Payable	54	58	59	59	154	103	101	225	124	214
Current Deferred & Payable Income Tax Liabilities	0.00	11	20	30	5.52	-	-	2.51	-	4.92
Other Current Liabilities	99	102	104	110	174	189	196	470	323	363
Total Noncurrent Liabilities	234	260	258	255	419	464	465	1,036	445	1,053
Long-Term Debt	199	205	205	206	368	425	423	980	401	1,002
Noncurrent Deferred & Payable Income Tax Liabilities	4.70	14	12	12	3.76	3.25	2.86	7.40	2.59	4.43
Other Noncurrent Operating Liabilities	30	40	39	36	45	36	39	49	41	46
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	40	14	14	18	-206	-204	-203	-238	-234	-234
Total Equity & Noncontrolling Interests	514	551	570	598	658	683	710	815	772	789
Total Preferred & Common Equity	510	548	566	594	653	679	705	800	765	776
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	510	548	566	594	653	679	705	800	765	776
Common Stock	315	353	357	363	396	402	411	478	463	473
Retained Earnings	195	196	209	231	258	277	293	323	302	302
Noncontrolling Interest	3.07	2.71	3.74	4.00	4.49	4.13	5.00	15	6.07	14

This table displays calculated financial ratios and metrics derived from Astrana Health's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	3/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	56,288,415.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	56,288,415.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	0.40
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Net Operating Profit after Tax (NOPAT)	-0.49	6.22	32	65	22	55	58	55	54	55	48
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	7.36%	6.09%	4.79%	2.61%
Earnings before Interest and Taxes (EBIT)	0.14	27	36	90	35	82	84	87	86	95	76
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	1.00	32	55	109	54	101	102	105	105	125	125
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-5.48	-298	155	-16	-55	64	43	-12	120	-194	-479
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	2.46	319	197	277	354	345	360	427	361	610	1,139
Increase / (Decrease) in Invested Capital	4.99	634	-123	80	77	-8.68	15	67	-66	249	527
Book Value per Share	($0.06)	$29.28	$26.51	$5.30	$5.49	$6.10	$8.07	$9.57	$10.54	$12.67	$13.84
Tangible Book Value per Share	($0.13)	($20.87)	($22.12)	($2.70)	($4.30)	$0.09	$2.14	$3.47	$4.53	$3.12	($6.34)
Total Capital	7.74	501	338	407	603	686	694	763	689	949	1,597
Total Debt	8.73	0.29	1.23	0.56	242	241	184	204	278	435	1,039
Total Long-Term Debt	7.69	0.00	0.62	0.52	232	230	183	203	259	425	991
Net Debt	3.72	-100	-140	-143	-7.45	-100	-145	-132	-50	96	581
Capital Expenditures (CapEx)	0.04	6.61	2.08	1.17	1.04	1.11	19	23	29	8.03	10
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-0.09	-28	-84	-7.14	13	-27	4.01	-13	-34	-8.57	-134
Debt-free Net Working Capital (DFNWC)	4.92	61	35	101	233	234	291	280	262	282	296
Net Working Capital (NWC)	3.89	61	35	101	224	224	290	280	243	273	248
Net Nonoperating Expense (NNE)	0.86	-0.72	-13	4.23	4.50	-67	12	9.32	-3.36	5.27	24
Net Nonoperating Obligations (NNO)	3.45	-100	-140	-130	-7.18	-100	-151	-132	-49	96	581
Total Depreciation and Amortization (D&A)	0.86	36	19	19	19	20	19	18	19	30	50
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	($1.33)	$0.00	$0.33	$0.41	$1.04	$1.69	$0.00	$1.30	$0.91	$0.46
Adjusted Weighted Average Basic Shares Outstanding	0.00	30.42M	0.00	32.89M	34.71M	36.53M	55.96M	0.00	55.42M	56.25M	55.60M
Adjusted Diluted Earnings per Share	$0.00	($1.38)	$0.00	$0.29	$0.39	$1.01	$1.63	$0.00	$1.29	$0.90	$0.46
Adjusted Weighted Average Diluted Shares Outstanding	0.00	5.75M	0.00	37.91M	36.40M	37.45M	55.96M	0.00	55.42M	56.25M	55.60M
Adjusted Basic & Diluted Earnings per Share	$0.00	($1.79)	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	10.43M	0.00	35.80M	52.80M	54.59M	55.96M	0.00	55.42M	56.25M	55.60M
Normalized Net Operating Profit after Tax (NOPAT)	-0.49	6.39	35	67	24	55	58	55	54	55	48
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-

This table displays calculated financial ratios and metrics derived from Astrana Health's official financial filings.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025
Period end date	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	56,288,415.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	56,288,415.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	0.11
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Net Operating Profit after Tax (NOPAT)	15	29	0.39	21	21	20	0.50	13	12	3.65	16
Return On Investment Capital (ROIC_SIMPLE)	-	-	0.04%	-	-	-	0.04%	1.14%	1.04%	0.20%	0.88%
Earnings before Interest and Taxes (EBIT)	29	41	-0.72	27	36	31	1.39	15	21	19	20
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	34	45	4.53	33	44	38	9.97	23	29	36	37
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-22	27	66	7.40	-85	-31	-249	-150	1.79	-558	-511
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	446	501	361	464	551	552	610	627	562	1,114	1,139
Increase / (Decrease) in Invested Capital	37	2.15	-66	14	105	51	249	163	11	562	527
Book Value per Share	$9.84	$10.32	$10.54	$11.79	$12.12	$12.53	$12.67	$13.25	$13.65	$13.83	$13.84
Tangible Book Value per Share	$3.78	$4.24	$4.53	$2.23	$2.73	$3.31	$3.12	$3.86	$4.33	($6.65)	($6.34)
Total Capital	792	825	689	843	921	945	949	934	952	1,605	1,597
Total Debt	209	209	278	390	442	438	435	416	414	1,050	1,039
Total Long-Term Debt	206	206	259	369	425	423	425	404	401	1,002	991
Net Debt	-138	-115	-50	11	72	44	96	109	24	559	581
Capital Expenditures (CapEx)	11	4.11	7.06	0.37	0.00	0.00	2.53	3.07	1.42	2.55	3.06
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-16	-0.70	-34	-133	-50	-51	-8.57	3.59	-60	-162	-134
Debt-free Net Working Capital (DFNWC)	282	276	262	204	278	299	282	265	282	302	296
Net Working Capital (NWC)	279	273	243	184	261	284	273	252	269	254	248
Net Nonoperating Expense (NNE)	-2.48	0.79	0.49	4.31	-1.26	1.14	8.28	7.11	2.13	2.57	9.52
Net Nonoperating Obligations (NNO)	-137	-114	-49	11	73	45	96	109	24	559	581
Total Depreciation and Amortization (D&A)	4.49	4.54	5.25	5.55	7.44	7.26	8.58	7.54	7.95	17	18
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.28	$0.47	$0.27	$0.31	$0.40	$0.34	($0.14)	$0.14	$0.19	$0.01	$0.12
Adjusted Weighted Average Basic Shares Outstanding	57.56M	46.55M	55.42M	56.03M	56.21M	56.25M	56.25M	56.06M	56.06M	56.29M	55.60M
Adjusted Diluted Earnings per Share	$0.28	$0.47	$0.26	$0.31	$0.40	$0.33	($0.14)	$0.14	$0.19	$0.01	$0.12
Adjusted Weighted Average Diluted Shares Outstanding	57.56M	46.92M	55.42M	56.03M	56.21M	56.25M	56.25M	56.06M	56.06M	56.29M	55.60M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	57.56M	58.28M	55.42M	56.03M	56.21M	56.25M	56.25M	56.06M	56.06M	56.29M	55.60M
Normalized Net Operating Profit after Tax (NOPAT)	15	29	-2.71	21	21	20	0.50	13	12	13	16
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-

Financials Breakdown Chart

Key Financial Trends

Here are the key takeaways from Astrana Health's recent quarterly results and the trailing four-year trend, focused on revenue, margins, cash flow, and leverage. Bullets are ordered with positive items first, then neutral, then negative.

Revenue spike in 2025 Q3: Revenue jumped to approximately $956.0M in Q3 2025, then stayed near that level in Q4 2025 at about $950.5M, suggesting a potential growth catalyst or one-time contribution rather than steady quarterly growth.
Net income remained positive in 2025: The company delivered positive net income across multiple 2025 quarters, with EPS ranging from about $0.01 (Q3 2025) to $0.19 (Q2 2025) and $0.12 in Q4 2025.
Operating cash flow generally positive in 2025: Net cash from continuing operating activities was strong in several 2025 quarters (e.g., $90.9M in Q2 2025 and $9.96M in Q3 2025), indicating improving cash-generation capability despite occasional fluctuations.
Liquidity improvement into Q3 2025: Cash and equivalents rose to around $462.2M in Q3 2025 from about $339.7M in Q2 2025, boosting near-term liquidity buffers.
Revenue volatility may reflect non-operational factors: The large Q3 2025 spike plus a subsequent plateau could reflect one-time deals or acquisitions rather than a sustained organic growth trend.
Asset intensity and impairment risk: Goodwill (~$863M in Q3 2025) and substantial intangible assets (~$285M) indicate a high asset base with potential impairment risk and future amortization considerations.
Significant financing activity in 2025: A large debt issuance (~$707M in Q3 2025) supported liquidity but increases future interest costs and leverage exposure.
Q4 2025 cash flow from operations turned negative: Net cash from continuing operating activities was around -$2.89M, and total net change in cash for the quarter was around -$30.28M, signaling a cash burn in that period.
Leverage remains elevated: Total liabilities (~$1.68B in mid-2025) significantly exceed total equity (~$0.78B), indicating a higher debt load and increased leverage risk.
Funding reliance and quarterly volatility: Several quarters show cash-flow or earnings swings, with some quarters relying on financing activities to fund operations, raising questions about sustainability without stronger organic growth.

05/14/26 12:17 AM ETAI Generated. May Contain Errors.

Astrana Health Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Astrana Health's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Astrana Health's net income appears to be on an upward trend, with a most recent value of $24.08 million in 2025, falling from -$1.35 million in 2015. The previous period was $49.93 million in 2024. Check out Astrana Health's forecast to explore projected trends and price targets.

Astrana Health's total operating income in 2025 was $78.53 million, based on the following breakdown:

Total Gross Profit: $341.53 million
Total Operating Expenses: $263.01 million

Over the last 10 years, Astrana Health's total revenue changed from $32.99 million in 2015 to $3.18 billion in 2025, a change of 9,544.7%.

Astrana Health's total liabilities were at $1.66 billion at the end of 2025, a 97.5% increase from 2024, and a 10,286.6% increase since 2015.

In the past 10 years, Astrana Health's cash and equivalents has ranged from $5.01 million in 2015 to $429.47 million in 2025, and is currently $429.47 million as of their latest financial filing in 2025.

Over the last 10 years, Astrana Health's book value per share changed from -0.06 in 2015 to 13.84 in 2025, a change of -24,011.2%.

Related Companies

Financial statements for NASDAQ:ASTH last updated on 3/14/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Astrana Health (ASTH) Financials

Financials Breakdown Chart

Key Financial Trends

Astrana Health Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Astrana Health (ASTH) Financials

Annual Income Statements for Astrana Health

Quarterly Income Statements for Astrana Health

Annual Cash Flow Statements for Astrana Health

Quarterly Cash Flow Statements for Astrana Health

Annual Balance Sheets for Astrana Health

Quarterly Balance Sheets for Astrana Health

Annual Metrics And Ratios for Astrana Health

Quarterly Metrics And Ratios for Astrana Health

Financials Breakdown Chart

Key Financial Trends

Astrana Health Financials - Frequently Asked Questions

When does Astrana Health's financial year end?

How has Astrana Health's net income changed over the last 10 years?

What is Astrana Health's operating income?

How has Astrana Health's revenue changed over the last 10 years?

How much debt does Astrana Health have?

How much cash does Astrana Health have?

How has Astrana Health's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools